This bill requires the Louisiana Department of Health to set minimum reimbursement rates for nonemergency medical transportation services used by Medicaid recipients. It establishes a minimum payment of $14.50 per trip plus $2.10 per mile for transportation providers. The Louisiana Department of Health must implement these changes by October 1, 2026, through a Medicaid state plan amendment. This policy change directly affects transportation providers serving Medicaid patients and the state's healthcare administration.
This bill requires nursing homes in Louisiana to have a permanently installed generator or alternative power source on-site to ensure electricity during emergencies. Facilities must store fuel or other power generation materials either on-site or ensure they are delivered before any emergency occurs. The law updates existing regulations to mandate these backup power capabilities for nursing facilities. This change directly affects nursing home operators who must now maintain specific power infrastructure and fuel supplies. The legislation focuses on improving emergency preparedness without specifying particular outcomes or advocating for a particular viewpoint.
This bill requires Louisiana Medicaid to cover FDA-approved weight loss medications for eligible adults over eighteen. To qualify, patients must have a BMI of 30 or higher with at least one related health condition like diabetes or hypertension, or a BMI of 35 or higher without additional conditions. Coverage will require prior authorization limited to verifying these eligibility criteria, with initial approval for six months and continued coverage depending on documented clinical improvement. The bill also prohibits step therapy requirements for these medications and mandates that the Department of Health implement the coverage while maintaining fiscal sustainability.
HB 944 creates the Louisiana Women's Health Consortium within the Louisiana Department of Health to address women's health needs across the state. The consortium will include 15 voting members representing health institutions (like Tulane School of Medicine and Woman's Hospital), government agencies (such as the surgeon general's office), and community stakeholders, plus nonvoting members from additional health organizations. Its core duties include developing a state funding plan for women's health initiatives, creating a comprehensive Women's Health Agenda focusing on issues like perimenopause and menopause, and identifying systemic barriers to care. The consortium must hold quarterly public meetings, submit an annual report to the legislature, and coordinate an online resource hub for evidence-based women's health information.
HB 807 establishes a special fund within Louisiana's state treasury to support the Community and Technical College System's workforce training programs. It directly affects community colleges and private-sector employers in high-demand industries like healthcare, manufacturing, and information technology by providing funding to hire more instructors and expand training capacity. Key provisions include using the fund for rapid-response instructor deployment, recruitment incentives, temporary instructors, and salary supplements - while prohibiting these funds from replacing existing state higher education funding. The program requires annual reporting to legislative committees on fund usage, supported industries, and credentials awarded.
HB 761 creates an advisory board within Louisiana's Department of Health to review and recommend new treatments for rare cancers. The 17-member board includes health officials, cancer researchers, oncologists from major institutions (like LSU, Tulane, and Xavier), and representatives from cancer research centers. The board must hold quarterly public meetings, compile findings within 30-45 days, and submit written reports to the Insurance Committees of both legislative chambers. This process directly affects how the Department of Health evaluates rare cancer treatments, streamlining recommendations to the agency for potential adoption.
HB 895 requires Louisiana hospitals and healthcare providers to offer sexual assault survivors specific medical treatments without undue delay. It mandates that providers make emergency contraception available and provide at least a three-day supply of HIV/STI prevention medication when medically needed, alongside private examinations adapted to each survivor's needs. The bill also requires hospitals to offer a survivor advocate (with confidential communications) during forensic exams, with the survivor's consent. This directly affects sexual assault survivors receiving emergency medical care in Louisiana hospitals.
HCR 120 establishes the PACE Task Force to study GLP-1 medications, which are drugs used for diabetes and weight loss that have seen a massive increase in demand and cost in Louisiana. This concurrent resolution directs the task force to investigate how these drugs affect insurance premiums, accessibility for different income groups, and the long-term financial impact on both public and private insurers. The group will consist of representatives from state agencies, health plans, and medical providers, who will meet to analyze pricing differences between diabetes and weight loss uses before submitting their findings to the legislature by February 2027.
This bill directs the United States Congress to collaborate on finding a cure for Sanfilippo Syndrome, a rare genetic disorder affecting children. The resolution calls for legislative action and support rather than establishing new funding or regulatory requirements. It was recently passed by the House of Representatives with unanimous support. The primary effect is a formal statement of intent to address this specific medical condition.
This resolution asks the Louisiana Commission on Law Enforcement and Administration of Criminal Justice to study how forensic medical exams for domestic violence survivors are currently handled across the state. The goal is to create consistent rules for these exams so that victims in rural areas receive the same care and evidence collection standards as those in cities. The commission will also look into making the payment process for these specialized medical services clearer and more reliable. To help with this study, the commission is invited to gather input from various groups, including hospitals, law enforcement agencies, and domestic violence advocates. Finally, the commission must submit its findings and suggestions to the legislature by June 2027.
